Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 1 institution in 1 country.
Ana Pozo-RodríguezDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.ORCID 0000-0003-1524-4131
Juan A Méndez-LíterDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.
Rocío García-VillalbaDepartment of Quality, Safety and Bioactivity of Plant Foods, Centro de Edafología y Biología Aplicada del Segura, Spanish National Research Council (CEBAS, CSIC), Espinardo, 30100 Murcia, Spain.
David BeltránDepartment of Quality, Safety and Bioactivity of Plant Foods, Centro de Edafología y Biología Aplicada del Segura, Spanish National Research Council (CEBAS, CSIC), Espinardo, 30100 Murcia, Spain.
Eva CalviñoDepartment of Structural and Chemical Biology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.
Andrés G SantanaDepartment of Chemistry of Natural and Synthetic Bioactive Products, Instituto de Productos Naturales y Agrobiología, Spanish National Research Council (IPNA, CSIC), Avda. Astrofísico Francisco Sánchez 3, 38206 San Cristóbal de La Laguna, Spain.ORCID 0000-0003-3568-7714
Laura I de EugenioDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.
Francisco Javier CañadaDepartment of Structural and Chemical Biology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.ORCID 0000-0003-4462-1469
Alicia PrietoDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.ORCID 0000-0002-5075-4025
Jorge BarriusoDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.ORCID 0000-0003-0916-6560
Francisco A Tomás-BarberánDepartment of Quality, Safety and Bioactivity of Plant Foods, Centro de Edafología y Biología Aplicada del Segura, Spanish National Research Council (CEBAS, CSIC), Espinardo, 30100 Murcia, Spain.ORCID 0000-0002-0790-1739
María Jesús MartínezDepartment of Microbial and Plant Biotechnology, Centro de Investigaciones Biológicas Margarita Salas, Spanish National Research Council (CIB, CSIC), C/Ramiro de Maeztu 9, 28040 Madrid, Spain.ORCID 0000-0003-2166-1097
Consejo Superior de Investigaciones Científicas · ES
Funding
Comunidad de Madrid RETOPROSOST-2-CM P2018/EMT-4459MICIU/AEI/FEDER RTI2018-093683-B-I00, RTI2018-094751-B-C22, PID2021-123781OB-C22
6 · The paper itself
Abstract
Resveratrol is a natural polyphenol with antioxidant activity and numerous health benefits. However, in vivo application of this compound is still a challenge due to its poor aqueous solubility and rapid metabolism, which leads to an extremely low bioavailability in the target tissues. In this work, rXynSOS-E236G glycosynthase, designed from a GH10 endoxylanase of the fungus
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis and Characterization of a Novel Resveratrol Xylobioside Obtained Using a Mutagenic Variant of a GH10 Endoxylanase. · full record | OpenQuestion